Filing Details
- Accession Number:
- 0001127602-18-010168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-05 17:20:07
- Reporting Period:
- 2018-03-01
- Accepted Time:
- 2018-03-05 17:20:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238337 | A Luke Pomilio | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-01 | 600 | $0.00 | 600 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-01 | 252 | $59.96 | 348 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-03-01 | 650 | $0.00 | 998 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-01 | 273 | $59.96 | 725 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-03-01 | 10,020 | $39.87 | 10,745 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-01 | 10,020 | $60.20 | 725 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-03-01 | 9,600 | $41.93 | 10,325 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-01 | 9,600 | $60.19 | 725 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-03-02 | 725 | $60.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Rsus (restricted Stock Units) | Disposition | 2018-03-01 | 600 | $0.00 | 600 | $0.00 |
Common Stock | Rsus (restricted Stock Units) | Disposition | 2018-03-01 | 650 | $0.00 | 650 | $0.00 |
Common Stock | Options To Purchase Common Stock | Disposition | 2018-03-01 | 10,020 | $0.00 | 10,020 | $39.87 |
Common Stock | Options To Purchase Common Stock | Disposition | 2018-03-01 | 9,600 | $0.00 | 9,600 | $41.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
600 | 2025-02-27 | No | 4 | M | Direct | |
1,300 | 2026-03-01 | No | 4 | M | Direct | |
30,060 | 2026-03-01 | No | 4 | M | Direct | |
38,400 | 2027-03-01 | No | 4 | M | Direct |
Footnotes
- Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period